Work

Third-Generation TKIs (Axitinib, Tivozanib) in RCC: Enhanced Efficacy and Diminished Toxicity?

Year: 2014

Type: book-chapter

Source: Springer eBooks

DOI: 10.1007/978-1-4939-1622-1_10

Authors: Hui Zhu, Brian I. Rini

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W123504964

FWCI:

Cites: 40

Cited by: 1

Related to: 10